WebJun 16, 2009 · This matter is before me on Plaintiff, PharmAthene, Inc.'s ("Plaintiff" or "PharmAthene"), request that the Court review in camera certain documents identified in … Web(c) to cause one of the PharmAthene Board Designees (the “Resigning PharmAthene Board Designee”) to resign upon the earlier of (i) such time as there has been a full settlement or a final, non-appealable resolution of that certain litigation matter between the Company and SIGA Technologies, Inc. (the “Siga Determination Date”) and (ii) the second anniversary of …
Delaware Court of Chancery Issues Ruling on Remand in PharmAthene …
WebJun 5, 2013 · The Supreme Court of the State of Delaware remanded SIGA Technologies v. PharmAthene back to the Delaware Court of Chancery after clarifying that a plaintiff may be awarded contract expectation damages for a breach of an obligation, contained in a contract, to negotiate in good faith. WebSIGA Techs., Inc. v. PharmAthene, Inc., No. 314,2012 (Del. May 24, 2013). Distress Transaction Blocked by Seller's Remorse. SIGA Technologies, Inc., lacking the financial resources to develop a vaccine, negotiated a license term sheet with PharmAthene, Inc. The term sheet specified the amounts of PharmAthene's payments and profit-sharing rights. blackview ip68 manual
Annual Survey of Judicial Developments Pertaining to Venture
WebSIGA Techs., Inc. v. Pharmathene, Inc. Supreme Court of Delaware. March 5, 2013, Submitted; May 24, 2013, Decided. No. 314, 2012. Opinion [*333] STEELE, Chief Justice: A Delaware corporation appeals from the Vice Chancellor's finding that it breached a contractual obligation to negotiate in good faith and is liable under the doctrine of … WebSIGA Technologies, Inc. v. Pharmathene, Inc. - Sullivan & Cromwell EN English Deutsch Français Español Português Italiano Român Nederlands Latina Dansk Svenska Norsk Magyar Bahasa Indonesia Türkçe Suomi Latvian … WebDec 16, 2011 · Two weeks later, on November 28, 2006, SIGA informed PharmAthene that those projections were stale and that SIGA now valued the drug at around $3 to $5 billion, … black view info for camera